C. Menendez-Botet

发表

Estrogen receptor protein of breast cancer as a predictor of recurrence

D. Kinne, J. Butler, S. Bretsky, 1985, Cancer.

Pathological review of breast lesions analyzed for estrogen receptor protein.

J. Urban, M. Schwartz, P. Rosen, 1975, Cancer research.

Micronutrient and cytokine interaction in congenital pediatric HIV infection.

A. Dnistrian, L. Noroski, S. Cunningham-Rundles, 1996, Journal of NutriLife.

Chemical and clinical evaluation of the continuous-flow analyzer "SMAC".

M. Fleisher, M. Schwartz, C. Menendez-Botet, 1974, Clinical chemistry.

The value of diagnostic aids in detecting pancreas cancer

C. Lightdale, S. Winawer, A. Cubilla, 1978, Cancer.

Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency

R. Motzer, H. Scher, G. Bosl, 2004, Cancer Chemotherapy and Pharmacology.

Murine mammary tumor virus related antigen in human male mammary carcinoma

R. Lloyd, M. Schwartz, P. Rosen, 1983, Cancer.

Pilot study of 5‐azacytidine (5‐AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia

P. Maslak, P. Maslak, A. Jakubowski, 1996, American journal of hematology.

Zinc deficiency, depressed thymic hormones, and T lymphocyte dysfunction in patients with hypogammaglobulinemia.

C. Cunningham-Rundles, R. Good, C. Menendez-Botet, 1981, Clinical immunology and immunopathology.

Estrogen and progesterone receptor content in human thyroid disease.

E. Strong, A. Huvos, C. Menendez-Botet, 1993, American journal of clinical pathology.

Fatal thrombocytopenia and liver failure associated with carboplatin therapy.

S. Sternberg, J. Boitnott, P. Meyers, 1991, Cancer investigation.

The relationship between family history, exposure to exogenous hormones, and estrogen receptor protein in breast cancer

M. Osborne, E. Beattie, P. Rosen, 1983, Cancer.

Principles & Practices of Point-of-Care Testing. Gerald J. Kost, ed. Philadelphia: Lippincott Williams & Wilkins, 2002, 672 pp., $95.00, cloth. ISBN: 0-7817-3156-9

C. Menendez-Botet, 2003 .

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

V. Rusch, L. Saltz, D. Niedzwiecki, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemical and physical properties of the disulfides of bovine neurophysin-II.

E. Breslow, C. Menendez-Botet, 1975, Biochemistry.

Small peptides as analogs of oxytocin and vasopressin in their interactions with bovine neurophysin-II.

E. Breslow, C. Menendez-Botet, J. Weis, 1973, Biochemistry.

Circulating thymic hormone levels in zinc deficiency.

R. Good, G. Fernandes, K. Pih, 1979, Cellular immunology.

Serum zinc levels in patients with basal-cell carcinoma.

B. Safai, R. Good, C. Menendez-Botet, 1981, The Journal of dermatologic surgery and oncology.

Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue.

M. Fleisher, J. Urban, M. Schwartz, 1976, Clinical chemistry.

A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.

H. Oettgen, C. Pinsky, M. Schwartz, 1978, Clinical chemistry.

Urine(or Both)of PatientswithCanceror BenignNeoplasms

H. Oettgen, C. Pinsky, C. Menendez-Botet, 1978 .

Estrogen Receptor Protein of Breast Cancer in Patients With Positive Nodes: High Recurrence Rates in the Postmenopausal Estrogen Receptor—Negative Group

M. Kimmel, B. Flehinger, M. Schwartz, 1987 .

Estrogen receptor protein in breast cancer as a predictor of recurrence

P. Rosen, R. Ashikari, D. Kinne, 1981, Cancer.

Estrogen and progesterone receptor proteins in patients with breast cancer.

M. Schwartz, C. Menendez-Botet, M. Schwartz, 1993, Advances in clinical chemistry.

Measurement of the estradiol receptor in human breast tissue by the immobilized antibody method.

C. Martucci, M. Schwartz, L. Hellman, 1975, The Journal of clinical endocrinology and metabolism.

Estrone and estradiol content in human breast tumors: relationship to estradiol receptors.

M. Schwartz, J. Fishman, C. Menendez-Botet, 1977, Journal of steroid biochemistry.

Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menses.

M. Osborne, D. Axelrod, D. Kinne, 1988, Cancer investigation.

Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer

J. Urban, M. Schwartz, P. Rosen, 1977, Cancer.

Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology

R. Senie, M. Schwartz, P. Rosen, 1981, Cancer.

Barr body distribution and estrogen receptor protein in mammary carcinoma.

M. Melamed, J. Urban, M. Schwartz, 1977, Annals of clinical and laboratory science.

9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.

M. Rubin, W. Miller, J. Mendelsohn, 1994, Cancer research.

Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.

R. Motzer, M. Mazumdar, G. Bosl, 1993, Cancer research.

Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions

R. Good, C. Menendez-Botet, Martin L. Lesser, 1980, Cancer.

The acute monocytic leukemias: multidisciplinary studies in 45 patients.

R. Mertelsmann, H. Broxmeyer, B. Clarkson, 1980, Medicine.

The value of diagnostic aids in detecting pancreas cancer

C. Lightdale, S. Winawer, A. Cubilla, 1978, Cancer.

Estrogen receptor protein in lesions of the male breast. A preliminary report

J. Urban, P. Rosen, C. Menendez-Botet, 1976, Cancer.